Cryptosporidium
Cryptosporidium spp.
General medical information for education only, not medical advice. Treatment considerations summarize published guidance at drug-class level; therapy is chosen by the treating clinician using susceptibility results, local resistance patterns and current guidelines.
Overview
A chlorine-tolerant protozoan parasite spread through recreational water, animals and person to person.
Infections
Cryptosporidiosis; chronic diarrhea in immunocompromised patients.
Signs and symptoms
Watery diarrhea, cramps, nausea, low fever.
Antibiotic and antimicrobial resistance
Drug resistance is not a recognized clinical problem; the available treatment, nitazoxanide, has limited effect in people with weakened immunity.
Treatment considerations
Supportive care; nitazoxanide in some patients.
Infection control and public health
Nationally notifiable; standard disinfectants are ineffective.

Sources
- CDC. Cryptosporidium.
- CDC DPDx. Cryptosporidiosis.
- IDSA. Infectious Diarrhea guideline.
Sources accessed November 2026. Links open external sites that InnovexLab does not control.
Medical disclaimer
This page is general educational information summarized from published public-health and professional-society guidance. It is not medical advice, a diagnosis or a treatment recommendation, and reading it does not create a clinician–patient relationship with InnovexLab. Decisions about testing, diagnosis and treatment belong to the treating clinician, using the patient’s history and examination, laboratory and susceptibility results, local resistance patterns and current guidelines. Guidance changes over time; consult the original sources for the latest version. InnovexLab provides this information as is and does not warrant that it is complete or current.
Patients with questions about their health should contact their own healthcare provider. In an emergency, call 911.